Toolkit/mass spectrometry

mass spectrometry

Assay Method·Research·Since 2022

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Mass spectrometry is an analytical assay method used to characterize light-induced modifications in therapeutic proteins. In the cited 2022 Journal of Pharmaceutical Sciences study, it was applied to detect and describe protein changes arising after light exposure.

Usefulness & Problems

Why this is useful

This method is useful for identifying and characterizing protein modifications associated with light exposure in therapeutic protein samples. The supplied evidence supports its role as an analytical readout for photodamage-related molecular changes.

Problem solved

It addresses the problem of determining what molecular modifications occur in therapeutic proteins after light exposure. The evidence indicates that mass spectrometric analysis was used to characterize these light-induced changes.

Problem links

enables peptide-level characterization beyond transcript-level inference

Literature

It addresses the need to detect active peptide products and release behavior rather than only transcript abundance. This is important where post-transcriptional complexity matters.

Source:

It addresses the need to detect active peptide products and release behavior rather than only transcript abundance. This is important where post-transcriptional complexity matters.

provides insights into membrane protein-lipid interactions

Literature

It helps generate new structural and functional insight into membrane proteins and lipid interactions.

Source:

It helps generate new structural and functional insight into membrane proteins and lipid interactions.

Published Workflows

Objective: Decipher genome complexity in the hypothalamic-neurohypophyseal system by connecting gene expression, peptide identity, cell-type-specific access, and causal functional interrogation to physiology and behavior.

Why it works: The review organizes complementary methods so that genome-scale expression discovery, peptide-level measurement, cell-type-specific labeling, and causal perturbation each address different layers of biological complexity in the HNS.

cis-regulatory complexitynoncoding and antisense mRNA contributionsalternative splicingpost-translational processing and modificationsomato-dendritic AVP signaling via local V1a receptorsOXT and AVP contributions to behaviortranscriptomicsmass spectrometrytransgenic fusion transgenescross-breeding to generate double transgenicsviral vectorsvirally mediated optogenetics

Stages

  1. 1.
    Transcriptomic discovery of HNS response genes(broad_screen)

    This stage provides broad candidate discovery at the gene-expression level before more targeted peptide, cellular, and functional interrogation.

    Selection: Identify genes involved in responses to physiological dehydration and pathological hypertension cues.

  2. 2.
    Single-cell peptide identification and release measurement(functional_characterization)

    This stage addresses peptide-level and release-level biology that is not captured by transcript measurements alone.

    Selection: Characterize biologically active peptides in the HNS and measure in vitro release.

  3. 3.
    Generation and use of transgenic and double transgenic lines(library_build)

    This stage provides identified neuronal populations that can be examined anatomically, electrophysiologically, and for activation responses.

    Selection: Create fusion-transgene lines and combine them by cross-breeding to enable study of AVP and OXT neurons.

  4. 4.
    Viral-vector functional demonstration of local AVP signaling(confirmatory_validation)

    This stage moves from descriptive access and measurement toward functional demonstration of a specific physiological mechanism.

    Selection: Demonstrate a physiological role for somato-dendritically released AVP acting through local V1a receptors.

  5. 5.
    Virally mediated optogenetic dissection of behavior(confirmatory_validation)

    This stage extends functional interrogation to behavior-level outcomes using targeted optical control.

    Selection: Dissect the roles of OXT and AVP in modulation of a wide variety of behaviors.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

No target processes tagged yet.

Input: Light

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: payload burdenimplementation constraint: spectral hardware requirementoperating role: sensor

The evidence indicates use of mass spectrometric analysis on therapeutic proteins following light exposure. No further practical details are provided regarding sample preparation, ionization method, fragmentation strategy, instrumentation, or data analysis pipeline.

The supplied evidence is limited to a study title and a high-level claim, so specific instrument types, workflows, detectable modification classes, and validation metrics are not available. Independent replication and generalizability beyond the cited context cannot be established from the provided material.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 2study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 3study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 4study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 5study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 6study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 7study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 8study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 9study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 10study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 11study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 12study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 13study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 14study focussupports2022Source 1needs review

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Claim 15review summarysupports2019Source 2needs review

Free-electron-laser-enabled diffraction techniques support time-resolved studies of biochemical reactions by providing very short, extremely intense X-ray bursts.

very short bursts of X-rays of extremely high intensity that are now accessible as a result of the construction of free-electron lasers, in particular to carry out time-resolved studies of biochemical reactions
Claim 16review summarysupports2019Source 2needs review

Recent advances in mass spectrometry, particularly in combination with other techniques, can generate fundamentally new insights into membrane protein properties and their functional interactions with lipid molecules.

recent advances in mass spectrometry, particularly in combination with other techniques, can generate fundamentally new insights into the properties of membrane proteins and their functional interactions with lipid molecules
Claim 17application summarysupports2012Source 3needs review

The review presents virally mediated optogenetics as a method to dissect the roles of OXT and AVP in modulating a wide variety of behaviors.

the use of virally-mediated optogenetics to dissect the role of OXT and AVP in the modulation of a wide variety of behaviours
Claim 18mechanistic summarysupports2012Source 3needs review

The review states that viral vectors were used to demonstrate that somato-dendritically released AVP contributes to cardiovascular homeostasis through V1a receptors on local somata and dendrites.

the use of viral vectors to demonstrate that somato-dendritically released AVP plays an important role in cardiovascular homeostasis by binding to V1a receptors on local somata and dendrites
Claim 19review scope summarysupports2012Source 3needs review

The review describes fusion-transgene transgenic lines and double transgenic lines as tools for studying AVP and OXT neurons in the HNS, including neuroanatomy, electrophysiology, and activation after stimuli.

transgenic lines that express fusion transgenes enabling (by cross-breeding) the generation of double transgenic lines that can be used to study vasopressin (AVP) and oxytocin (OXT) neurones in the HNS, as well as their neuroanatomy, electrophysiology and activation upon exposure to any given stimulus
Claim 20review scope summarysupports2012Source 3needs review

The review presents mass spectrometry as enabling single-cell identification of biologically active peptides in the HNS and measurement of in vitro release.

the use of mass spectrometry for single-cell level identification of biological active peptides in the HNS, and to measure in vitro release
Claim 21review scope summarysupports2012Source 3needs review

The review presents transcriptomics as a method to identify genes involved in HNS responses to dehydration and hypertension.

the use of transcriptomics to identify genes involved in the response to physiological (dehydration) and pathological (hypertension) cues

Approval Evidence

3 sources3 linked approval claimsfirst-pass slug mass-spectrometry
A Mass Spectrometric Characterization of Light-Induced Modifications in Therapeutic Proteins

Source:

recent advances in mass spectrometry, particularly in combination with other techniques, can generate fundamentally new insights into the properties of membrane proteins and their functional interactions with lipid molecules

Source:

the use of mass spectrometry for single-cell level identification of biological active peptides in the HNS, and to measure in vitro release

Source:

study focussupports

The paper characterizes light-induced modifications in therapeutic proteins using mass spectrometric analysis.

Source:

review summarysupports

Recent advances in mass spectrometry, particularly in combination with other techniques, can generate fundamentally new insights into membrane protein properties and their functional interactions with lipid molecules.

recent advances in mass spectrometry, particularly in combination with other techniques, can generate fundamentally new insights into the properties of membrane proteins and their functional interactions with lipid molecules

Source:

review scope summarysupports

The review presents mass spectrometry as enabling single-cell identification of biologically active peptides in the HNS and measurement of in vitro release.

the use of mass spectrometry for single-cell level identification of biological active peptides in the HNS, and to measure in vitro release

Source:

Comparisons

Source-stated alternatives

The review contrasts or complements mass spectrometry with other biophysical and computational techniques, including diffraction approaches and combined-method strategies.; The review contrasts this peptide-focused approach with transcriptomics for gene discovery and with transgenic, viral-vector, and optogenetic methods for functional dissection.

Source:

The review contrasts or complements mass spectrometry with other biophysical and computational techniques, including diffraction approaches and combined-method strategies.

Source:

The review contrasts this peptide-focused approach with transcriptomics for gene discovery and with transgenic, viral-vector, and optogenetic methods for functional dissection.

Source-backed strengths

A key strength supported by the evidence is its ability to characterize light-induced modifications in therapeutic proteins at the molecular level. The available source does not provide additional performance details such as sensitivity, site resolution, throughput, or quantitative accuracy.

Compared with optogenetic

The review contrasts this peptide-focused approach with transcriptomics for gene discovery and with transgenic, viral-vector, and optogenetic methods for functional dissection.

Shared frame: source-stated alternative in extracted literature

Strengths here: described as generating fundamentally new insights when combined with other techniques; supports single-cell level peptide identification; supports direct measurement of in vitro release.

Relative tradeoffs: the abstract does not specify which mass spectrometry modality or its practical limitations; the abstract does not specify the exact mass spectrometry modality or HNS-specific protocol details.

Source:

The review contrasts this peptide-focused approach with transcriptomics for gene discovery and with transgenic, viral-vector, and optogenetic methods for functional dissection.

Ranked Citations

  1. 1.
    StructuralSource 1Journal of Pharmaceutical Sciences2022Claim 1Claim 2Claim 3

    Extracted from this source document.

  2. 2.
    StructuralSource 2Annual Review of Biochemistry2019Claim 15Claim 16

    Seeded from load plan for claim c3. Extracted from this source document.

  3. 3.
    StructuralSource 3Journal of Neuroendocrinology2012Claim 17Claim 18Claim 19

    Seeded from load plan for claim cl2. Extracted from this source document.